Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹9 Cr.
Stock P/E
21
P/B
0.9
Current Price
₹22.6
Book Value
₹ 26
Face Value
10
52W High
₹35.9
52W Low
₹ 19.5
Dividend Yield
0%

DhanvantriJeevan Rek Overview

Business

Dhanvantri Jeevan Rekha Ltd. operates in the Hospital & Healthcare Services sector in India. Its core business model likely involves providing a range of medical services, including inpatient and outpatient care, diagnostic services, surgical procedures, emergency care, and potentially specialized treatments. The company generates revenue primarily through fees charged for these medical services, which include consultations, room charges, procedure fees, pharmacy sales, and diagnostic tests to patients, either directly or via insurance providers and government schemes.

Revenue Mix

While specific breakdowns are not available, typical revenue streams for a hospital and healthcare services company like Dhanvantri Jeevan Rekha Ltd. would include:

Inpatient Services: Revenue from patient admissions, surgeries, long-term care, and associated room and board charges.

Outpatient Services: Income from consultations, day-care procedures, and minor treatments.

Diagnostic Services: Fees from lab tests, imaging (X-rays, MRI, CT scans), and other diagnostic procedures.

Pharmacy & Allied Services: Sales of medicines, medical supplies, and other ancillary services.

Emergency & Critical Care: Revenue from urgent care and intensive care units.

Industry

The Indian healthcare services industry is characterized by significant growth, driven by a large and growing population, increasing disposable incomes, rising health awareness, and a growing prevalence of lifestyle diseases. It is a fragmented market with a mix of large corporate hospital chains, regional hospital groups, single-specialty hospitals, and standalone clinics. Without specific operational details, Dhanvantri Jeevan Rekha Ltd. likely positions itself based on factors such as geographic location, specialty focus (e.g., multi-specialty, cardiology, orthopedics), service quality, technology infrastructure, and pricing strategy within its target markets.

MOAT

Potential competitive advantages for a hospital and healthcare services provider often stem from:

Brand Reputation & Trust: A strong reputation for quality medical outcomes, patient care, and ethical practices.

Physician Network: The ability to attract and retain highly skilled and renowned doctors, which directly impacts patient inflow.

Specialized Infrastructure: Investments in advanced medical technology and facilities for complex procedures.

Geographic Dominance: Being the leading healthcare provider in a specific region or locality, creating convenience for patients.

Switching Costs: For patients with chronic conditions or those requiring long-term care, switching hospitals can be inconvenient.

Growth Drivers

Key factors that can drive growth for Dhanvantri Jeevan Rekha Ltd. over the next 3-5 years include:

Demographic Shifts: India's large and aging population and increasing prevalence of chronic diseases.

Rising Healthcare Expenditure: Growth in public and private spending on healthcare.

Medical Tourism: Leveraging India's cost-effective quality healthcare to attract international patients.

Technological Advancements: Adoption of new medical technologies and digital health solutions (e.g., telemedicine, AI diagnostics).

Government Initiatives: Policy support and schemes aimed at expanding healthcare access and insurance penetration (e.g., Ayushman Bharat).

Expansion: Opening new facilities or expanding existing capacities in underserved or high-growth areas.

Risks

Regulatory & Policy Changes: Evolving government regulations regarding pricing, quality standards, and healthcare reforms.

Intense Competition: Competition from existing large hospital chains, new entrants, and regional players.

Talent Retention: Challenges in attracting and retaining qualified doctors, nurses, and allied healthcare professionals.

Capital Expenditure Needs: The healthcare sector is capital-intensive, requiring continuous investment in infrastructure, technology, and upgrades.

Medical Malpractice & Litigation Risks: Exposure to legal challenges related to patient care and outcomes.

Insurance Reimbursement Issues: Delays or reductions in payments from public and private insurance providers.

Economic Downturns: Reduced discretionary spending on healthcare during economic contractions.

Management & Ownership

As a listed entity (DHAN JEEVAN), Dhanvantri Jeevan Rekha Ltd. would typically have a professional management team overseen by a Board of Directors. The ownership structure would likely involve promoter holdings, institutional investors, and public shareholders. Without specific names or details, it's presumed that the promoters and management would be responsible for strategic direction, operational efficiency, and financial performance within the highly regulated healthcare environment.

Outlook

Dhanvantri Jeevan Rekha Ltd. operates within a fundamentally strong and growing sector in India, driven by favorable demographics and increasing healthcare awareness. The long-term demand for quality healthcare services provides a significant tailwind for growth. However, the company faces inherent challenges common to the industry, including intense competition, the need for continuous capital investment in technology and infrastructure, regulatory complexities, and the constant demand for highly skilled medical professionals. Success will depend on its ability to differentiate through service quality, strategic expansion, efficient cost management, and adept navigation of the regulatory landscape.

DhanvantriJeevan Rek Share Price

Live · BSE · Inception: 1993
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

DhanvantriJeevan Rek Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 5 6 5 6 6 6 6 7 7 8
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 6 6 6 6 6 6 6 7 7 8
Total Expenditure 5 5 5 6 6 5 6 7 7 8
Operating Profit 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 0 -0 0 0 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax -0 0 0 0 0 0 -0 0 0 0
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -0 0 0 0 0 0 -0 0 0 0
Adjusted Earnings Per Share -0.2 0.4 0.4 0.4 0.1 0.1 -0.3 0.4 0.7 0.4

DhanvantriJeevan Rek Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 8 9 11 14 17 18 10 17 18 20 23 28
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 8 10 12 14 17 18 10 17 18 21 23 28
Total Expenditure 6 8 10 12 16 18 11 15 17 20 22 28
Operating Profit 2 2 2 2 1 1 -1 2 1 1 1 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 1 1 1 1 1 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 1 1 1 0 -0 -2 1 -0 0 1 0
Provision for Tax 0 0 0 -0 0 -0 -0 0 0 0 0 0
Profit After Tax 1 1 1 1 0 -0 -1 0 -0 0 1 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 1 1 1 0 -0 -1 0 -0 0 1 0
Adjusted Earnings Per Share 2.6 2.3 1.3 1.8 0.1 -0.6 -3.5 1.2 -0.5 0.4 1.2 1.2

DhanvantriJeevan Rek Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 8 9 10 11 11 10 9 10 9 9 10
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 2 0 0 0 0 0 0 0
Other Non-Current Liabilities 1 1 2 1 1 1 2 2 2 2 2
Total Current Liabilities 2 2 4 3 3 3 3 3 3 4 3
Total Liabilities 11 13 16 16 15 15 14 14 14 15 15
Fixed Assets 5 5 12 12 11 11 10 9 9 8 8
Other Non-Current Assets 2 3 1 1 1 1 2 2 2 1 2
Total Current Assets 4 4 3 3 3 3 2 4 4 6 5
Total Assets 11 13 16 16 15 15 14 14 14 15 15

DhanvantriJeevan Rek Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 1 1 1 0 1 1 2 1 3
Cash Flow from Operating Activities 1 1 4 1 1 1 -0 1 -0 3 -0
Cash Flow from Investing Activities -1 -1 -4 -1 -0 -0 -0 -0 -1 -0 -1
Cash Flow from Financing Activities 0 0 1 -0 -2 -0 -0 -0 0 0 0
Net Cash Inflow / Outflow -0 0 0 0 -1 1 -0 1 -1 3 -1
Closing Cash & Cash Equivalent 0 1 1 1 0 1 1 2 1 3 3

DhanvantriJeevan Rek Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.61 2.33 1.33 1.78 0.11 -0.64 -3.47 1.2 -0.53 0.4 1.23
CEPS(Rs) 3.49 2.98 2.24 4.47 2.86 2.04 -0.92 3.68 1.8 2.52 2.61
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 20.48 22.8 24.14 25.91 26.03 25.38 21.91 23.11 22.58 22.98 24.58
Core EBITDA Margin(%) 19.22 15.64 10.42 13.49 7.32 3.65 -7.66 8.9 3.28 4.08 3.17
EBIT Margin(%) 20.14 16.12 10.22 6.49 1.37 -1.5 -16.45 4.11 -0.78 1.28 2.51
Pre Tax Margin(%) 19.12 15.24 8.65 4.9 0.69 -1.74 -16.67 4.01 -0.82 1.25 2.45
PAT Margin (%) 13.4 10.3 4.89 5.3 0.28 -1.45 -14.55 2.92 -1.23 0.81 2.23
Cash Profit Margin (%) 17.95 13.19 8.22 13.32 6.97 4.59 -3.87 8.98 4.18 5.04 4.73
ROA(%) 10.82 7.95 3.77 4.46 0.3 -1.76 -10.03 3.51 -1.54 1.15 3.4
ROE(%) 14.25 10.75 5.68 7.1 0.44 -2.51 -14.69 5.31 -2.31 1.77 5.19
ROCE(%) 21.14 16.71 11.79 7.91 1.97 -2.55 -16.37 7.4 -1.46 2.78 5.8
Receivable days 22.61 23.41 11.64 11.41 18.47 14.93 28.42 30.28 42.97 37.5 28.6
Inventory Days 0.42 0.49 0.49 0.88 1.74 2.21 3.71 2.23 2.67 2.38 2.24
Payable days 0 0 0 0 0 0 0 0 -9882.22 0 0
PER(x) 5.85 13.11 42.55 17.02 133.1 0 0 13.96 0 60.76 16.73
Price/Book(x) 0.74 1.34 2.35 1.17 0.58 0.21 0.34 0.72 0.58 1.07 0.84
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.75 1.29 1.99 0.96 0.37 0.06 0.23 0.3 0.25 0.32 0.26
EV/Core EBITDA(x) 3.02 6.76 14.7 6.63 4.58 1.22 -3.94 2.95 5.47 5.8 5.23
Net Sales Growth(%) 9.82 16.08 20.63 23.04 22.53 8.16 -46.28 71.42 5.49 15.7 10.69
EBIT Growth(%) 76.38 -7.11 -23.51 -21.8 -74.09 -218.05 -489.54 142.85 -119.94 289.89 117.69
PAT Growth(%) 91.65 -10.77 -42.71 33.38 -93.57 -664.39 -438.61 134.43 -144.21 176.27 206.28
EPS Growth(%) 91.65 -10.77 -42.71 33.38 -93.57 -664.61 -438.61 134.44 -144.21 176.26 206.27
Debt/Equity(x) 0 0 0 0.18 0.01 0.01 0.01 0 0 0 0
Current Ratio(x) 1.83 1.94 0.78 1.03 0.8 0.91 0.81 1.21 1.24 1.44 1.49
Quick Ratio(x) 1.82 2.83 1.4 1.67 1.37 1.46 1.68 3.04 4.57 3.98 3.79
Interest Cover(x) 19.79 18.35 6.5 4.07 2.02 -6.3 -76.08 42.19 -19.82 46.9 45.79
Total Debt/Mcap(x) 0 0 0 0.16 0.02 0.05 0.02 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +15% +11% +5% +11%
Operating Profit CAGR 0% -21% 0% -7%
PAT CAGR — — — 0%
Share Price CAGR -27% +24% +19% -2%
ROE Average +5% +2% -1% +3%
ROCE Average +6% +2% 0% +5%

DhanvantriJeevan Rek Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 19.65 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 80.35 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 19.6519.6519.6519.6519.6519.6519.6519.6519.6519.65
FII 0000000000
DII 0000000000
Public 80.3580.3580.3580.3580.3580.3580.3580.3580.3580.35
Others 0000000000
Total 100100100100100100100100100100

DhanvantriJeevan Rek Peer Comparison

Hospital & Healthcare Services Edit Columns

DhanvantriJeevan Rek Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

DhanvantriJeevan Rek Pros & Cons

Pros

  • Stock is trading at 0.9 times its book value
  • Company is almost debt free.

Cons

  • Promoter holding is low: 19.65%.
  • Company has a low return on equity of 2% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp